Yoshida S, Takahara T, Tanaka H, Yokoyama M, et al. The role of prostate-specific antigen changes in predicting overall survival after progressive-site directed therapy for oligoprogressive castration-resistant prostate cancer. Int J Urol 2023 Mar 31. doi: 10.1111/iju.15185.
PMID: 37000986